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E-mail addresses: g.vanmeer@uu.nl (G. van Meer),When acquiring internal membranes and vesicular transport, eukaryotic cells started to synthesize
sphingolipids and sterols. The physical differences between these and the glycerophospholipids
must have enabled the cells to segregate lipids in the membrane plane. Localizing this event to
the Golgi then allowed them to create membranes of different lipid composition, notably a thin,
ﬂexible ER membrane, consisting of glycerolipids, and a sturdy plasma membrane containing at
least 50% sphingolipids and sterols. Besides sorting membrane proteins, in the course of evolution
the simple sphingolipids obtained key positions in cellular physiology by developing speciﬁc inter-
actions with (membrane) proteins involved in the execution and control of signaling. The few sig-
naling sphingolipids in mammals must provide basic transmission principles that evolution has
built upon for organizing the speciﬁc regulatory pathways tuned to the needs of the different cell
types in the body.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Sphingolipid synthesis in mammalian cells
The ﬁrst step in sphingolipid synthesis is the condensation of
palmitoyl-SCoA and serine to 3-ketodihydrosphingosine by serine
palmitoyltransferase, SPT. This lipid is reduced to dihydrosphingo-
sine, also named sphinganine, essentially all of which is converted
to dihydroceramide by the attachment of a fatty acid to the amino-
group at C2 of the sphinganine backbone (Fig. 1). This reaction is
catalyzed by one of the ceramide synthases, a family of enzymes
that have different fatty acid speciﬁcities [1]. Most dihydrocera-
mides are desaturated at C4–C5, to yield ceramide with sphingo-
sine (sphingenine) as a sphingoid base. Dependent on the cell
type a fraction of the dihydroceramides is hydroxylated at C4 to
yield phytoceramide, which has a phytosphingosine (4-hydroxy-
sphinganine) backbone. Ceramide synthases also yield ceramides
directly from sphingosine that originates from sphingolipid
hydrolysis in the lysosomes, the salvage pathway [2]. Until this
point all events occur on the cytosolic surface of the ER membrane.
Ceramide may also be produced in other parts of the cell from
sphingosine and fatty acid via the reverse action of ceramidases,
or by the action of sphingomyelinases. Sphingosine can also be
phosphorylated by sphingosine kinase to sphingosine-1-phosphate
at the inside of the plasma membrane [3]. This latter lipid is
recycled to sphingosine by the ER phosphatases SPP1 and 2, orchemical Societies. Published by E
s.hotzl@uu.nl (S. Hoetzl).degraded by the ER lyase into hexadecenal (to be reduced to palmi-
tate) and ethanolamine-phosphate.
In most cells, the bulk of the ceramide is converted to sphingo-
myelin (SM) by sphingomyelin synthase 1 (SMS1), on the lumenal
surface of the trans-Golgi, or by SMS2 on the outer surface of the
plasma membrane [4,5]. Both SMS1 and 2 contribute to cellular
SM synthesis [6]. Alternatively, ceramide is galactosylated by the
galactosyltransferase Gal-T 1 on the lumenal surface of the ER
membrane, or glucosylated by glucosylceramide (GlcCer) synthase
on the cytosolic surface of a Golgi membrane (or the ER in ﬂies [7]).
Galactosylceramide (GalCer) can be sulfated by a sulfotransferase
to sulfatide (SGalCer) in the trans-Golgi. In contrast, GlcCer can
be converted by lactosylceramide (LacCer) synthase. LacCer can
be further glycosylated to an array of different glycosphingolipids
(GSLs) by the stepwise addition of monosaccharides. Essentially
every cell contains GM3 (sialic acid–galactose–glucose–ceramide),
and most cells express at least one additional glycolipid synthesis
pathway. In contrast to the synthesis of the precursor GlcCer, these
glycosylation reactions occur in the lumen of the Golgi.
GSLs and SM are broken down to sphingosine by a series of ded-
icated enzymes in the lysosomal lumen. The GSLs are ﬁrst de-
graded to ceramide by the removal of the sugars by a set of acid
hydrolases, most of which require a helper protein for their activity
[8]. The phosphocholine headgroup of SM is removed by acid
sphingomyelinase [9], after which ceramide is degraded by acid
ceramidase. Alternatively, SM is hydrolyzed to ceramide by the
neutral sphingomyelinase (nSMase2) on the cytosolic surface of
the plasma membrane [10]. Also ceramide can be degraded outsidelsevier B.V. All rights reserved.
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Fig. 1. Biosynthetic and hydrolytic pathways of some common sphingolipids. The sphingoid bases sphinganine (not shown), sphingosine and 4-hydroxysphinganine
(phytosphingosine) can be N-acylated to ceramide, which forms the basis for sphingomyelin and the glycosphingolipids (except the glycosylsphingosines). Lactosylceramide
can be converted to a number of different higher glycolipids, each giving rise to a distinct series. One ganglioside series is shown leading to GM1, whose pentasaccharide
headgroup is depicted. The biosynthetic enzymes are depicted in blue. CGT, ceramide galactosyltransferase and GCS, GlcCer synthase. The hydrolytic enzymes are indicated in
red with, in italics, the relevant activator protein [8].
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ma membrane [11] or by one of the three alkaline ceramidases
[12].
2. Sphingolipid topology and transport
2.1. Sphingoid bases and signaling receptors
The sphingoid bases possess the physical property that they rap-
idly exchange between membrane surfaces across the aqueous
phase because of the fact that their single lipid tail is only a weak
membrane anchor and because they have a polar head group due
to the partially charged amino group. When present on a cytosolic
surface, they can therefore be expected to rapidly equilibrate be-
tween the cytosolic surfaces of all organelles. In addition, sphingoid
bases readily move across membranes at neutral pH. At acidic pH
the aminomoiety no longer partially occurs as an uncharged amine
but becomes positively charged which antagonizes spontaneous
transport. It is therefore very likely that the sphingosine that is gen-
erated in the lysosomes andmust reach the ERmembrane for reuti-
lization can onlymove across the lysosomalmembrane bymeans of
an active transporter. An involvement has been proposed for the
Niemann-Pick C protein NPC1 [13]. Likewise, sphingosine-1-phos-
phate is synthesized by a kinase in the cytosol but has extracellular
functions and must cross the plasma membrane. It has been re-
ported that the transmembrane translocation is mediated by themultidrug ABC transporters ABCC1 and ABCA1 (see [3]). Extracellu-
lar sphingosine-1-phosphate can bind to sphingosine-1-phosphate
receptors, a family of G protein-coupled receptors on the surface of
cells [3].
2.2. Ceramide and signaling
In contrast to sphingosine, ceramide is deeply embedded in the
membrane. Like any other lipid it laterally diffuses in the ﬂuid cel-
lular membranes, but in contrast to lipids that have a large or
charged headgroup, ceramide rapidly moves across membranes
spontaneously [14]. It does not move between membranes as a
monomer at a signiﬁcant rate. For example, ceramide produced in
the lysosomes must be degraded to sphingosine to be able to leave
the lysosomes: inactivating mutations in acid ceramidase cause the
ceramide storage disorder Farber disease, probably because cera-
mide is produced in the intralumenal vesicles of lysosomes and is
unable to reach the limiting membrane (as is the case for choles-
terol in the cholesterol storage disease Niemann-Pick C). After syn-
thesis in the ER, ceramide reaches the site of SM synthesis in the
Golgi not by vesicular trafﬁc: this transport requires the ceramide
transfer protein CERT, which binds to a protein on the ER and to
the phosphoinositide PI-4-P on the Golgi, possibly at ER-Golgi con-
tact sites. CERT binding is regulated via phosphorylation [15]. Un-
der certain conditions new ceramide in the ER and ceramide
generated in the plasma membrane by sphingomyelinases activate
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Fig. 2. Pathways of intracellular GlcCer transport. (A) Under normal conditions,
ceramide (Cer) is transported to the trans-Golgi by the ceramide transport protein
CERT. GlcCer is synthesized on the cytosolic surface of the Golgi and is transported
back to the ER by FAPP2. It ﬂips across the ER membrane and is transported to the
lumen of the Golgi, possibly involving GlcCer and GalCer clustering at ER exit sites
[38]. In an alternative model (gray arrows) GlcCer synthesized in cis-Golgi is
transported to the trans-Golgi via FAPP2 where it ﬂips by an unknown mechanism
[37]. SM and all complex GSLs are synthesized on the lumenal surface. Cholesterol
has been shown to have a high afﬁnity for sphingolipids, which are thought to
reside mainly in the non-cytosolic leaﬂets. Unexpectedly, cholesterol was found
enriched in the opposed leaﬂet of the bilayer [87]. GlcCer also reaches the inside of
the plasma membrane and ﬂips across [38]. (B) In the presence of brefeldin A the
Golgi and ER merge. In the absence of vesicular trafﬁc from the ER, GlcCer and
GalCer are able to reach other cytosolic surfaces and translocate to the outside of
the plasma membrane (blue arrow), or the lumenal surface of endosomes (green
arrows) [38]. Vesicular trafﬁc between endosomes and plasma membrane contin-
ues (black arrows).
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that ceramides in a membrane can be recognized by proteins out-
side that membrane. Indeed, antibodies have been generated that
recognize ceramide in the membrane. However, interpretation of
the results is not always straightforward due to technical complica-
tions [17,18]. A high ceramide level in the ER has been correlated
with apoptosis. Possibly, this raises ceramide levels in the mito-
chondria and activates apoptotic pathways (see [19]). ER ceramide
levels should thus be controlled, and recently an ER member of the
family of SM synthases with low enzymatic activity towards cera-
mide, SMSr, has been proposed to be a ceramide sensor [20]. How
it couples to possible effectors is not yet known. It is also not clear
whether plasma membrane SMS2, having a side activity similar to
the activity of SMSr [21], has a sensor function as well. Although
mitochondria contain very low levels of SM [22], the existence of
a speciﬁc mitochondrial SM pool as a precursor for mitochondrial
‘‘apoptotic” ceramide has been suggested [23].
2.3. Sphingomyelin and lipid segregation
After delivery by CERT to the trans-Golgi, ceramide is converted
to SM in its lumen. In COP-I vesicles from the Golgi heading for the
ER the concentration of SM and cholesterol was found to be re-
duced as compared to that of the major phospholipid phosphati-
dylcholine [24], whereas sphingolipids and sterols were enriched
in secretory vesicles [25]. These ﬁndings illustrate the general prin-
ciple of lipid segregation in the Golgi, whereby SM, glyco-
sphingolipids and cholesterol are sorted towards the plasma
membrane while unsaturated PC is enriched in the retrograde
pathway. The location of SM and the complex GSLs in the lumenal
leaﬂet of the Golgi has thus led to the proposal that a lateral sorting
event occurs in this lumenal leaﬂet whereby sphingolipids and
cholesterol are enriched in areas of the membrane that are des-
tined for the plasma membrane, and PC in areas where the vesicles
bud that are bound for the ER [26]. The physical basis of this lipid
segregation into two domains that differ in the degree of order, or
ﬂuidity, has been worked out in great detail (see [27]). Although
the lateral segregation of lipids in Golgi membranes has not been
shown in a direct experiment, such evidence has been provided
for endosomes. In the latter case, however, the authors have made
use of ﬂuorescent analogs of membrane lipids, and it is not really
clear how the native lipids distribute over the various transport
pathways out of the endosomes: to the late endosomes, to the Gol-
gi, and back to the plasma membrane [28–33]. Because the direc-
tional delivery of membrane vesicles depends on the presence of
speciﬁc targeting proteins like SNAREs and Rabs, the two (or more)
lipid environments in the donor membrane must be able to recruit
the unique sets of proteins needed to ensure the delivery of the dif-
ferent membrane vesicles at the correct target membranes. That
certain proteins partition into more ordered membrane patches
has been operationally determined by their preferential partition-
ing into detergent-resistant membranes. Direct evidence at the le-
vel of vesicle budding is still lacking.
2.4. Monohexosylsphingolipids and their multiple transport
mechanisms
GalCer synthesized on the lumenal surface of the ER can reach
the lumen of the trans-Golgi (network), where it can be sulfated,
and the outside of the plasma membrane by vesicular trafﬁc
(Fig. 2). In contrast, GlcCer is synthesized on the cytosolic surface
of the Golgi [34–36]. In order for it to be converted to LacCer and
further complex GSLs on the lumenal surface, it must cross the
membrane (Fig. 2). Surprisingly, it was found that conversion to
the complex glycolipid GM3 depended on FAPP2, a cytosolic pro-
tein bound to the trans-Golgi via PI-4-P and possessing a glycolipidbinding domain. This was taken as evidence that FAPP2 trans-
ported GlcCer from the early Golgi to the trans-Golgi where it
was translocated to the lumen [37]. However, Halter et al. [38] pro-
vided evidence for transport of GlcCer back to the ER membrane
and across to the lumenal side, which would then be followed by
vesicular trafﬁc of GlcCer from the ER into the lumen of the Golgi
(just like GalCer). Such retrograde transport of GlcCer might occur
at the same contact site where CERT putatively transfers ceramide
in the anterograde direction [39]. Translocation of GlcCer across
the ER membrane would be expected from the fact that GlcCer rap-
idly translocated towards the lumen of the merged ER-Golgi com-
partment in the presence of brefeldin A, which fuses Golgi
membranes to the ER [38]. In addition, spin-labeled GlcCer and
GalCer easily translocated across isolated ER membranes without
ATP consumption [40]. Rapid translocation was also reported for
isolated total Golgi membranes, which leaves open the possibility
that spontaneous translocation can also occur across late [37] or
early [38] Golgi membranes.
Unexpectedly, it was found that both newly synthesized GlcCer
and GalCer still reached the surface of the plasma membrane in the
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the surface conﬁrming that under those conditions vesicular trafﬁc
from the merged ER-Golgi compartment to the plasma membrane
is fully blocked [38]. Therefore, GlcCer and GalCer must have
moved across the cytosol to the cytosolic side of the plasma mem-
brane, and subsequently they must have translocated across the
plasma membrane. Transport of GlcCer across the cytosol had been
reported [41]. The mechanism remains unclear, as no role for
FAPP2 or for the glycolipid transfer protein GLTP was observed
[38]. Translocation across the plasma membrane has been ob-
served for GlcCer analogs carrying one or two shortened fatty tails,
and it was found that this was mediated by the multidrug ABC
transporters ABCB1 [42] and ABCC1 [43]. In contrast, inhibition
or knock-out of these transporters did not affect transport of natu-
ral GlcCer and GalCer [38]. Interestingly, studies on the skin disor-
der harlequin ichthyosis have indicated that ABCA12 transports
GlcCer across the membrane of skin lamellar bodies, making it a
candidate for the translocation across plasma membranes (or
endosomal membranes) in non-skin cells (see [44]). The convo-
luted transport pathways of GlcCer may indicate that local GlcCer
concentrations are controlled. Also the non-lysosomal glucosylcer-
amidases may exert control on local GlcCer concentrations
[45–47]. GlcCer on the cytosolic surface of cell organelles appears
to exert functions in the sorting of membrane proteins to lyso-
somes and lysosome-related organelles [48,49]. GlcCer and the
complex GSLs derived from it are required for mammalian embry-
onic development [50].
2.5. Glycosphingolipids and clustering
Non-random distributions of GSLs were ﬁrst observed in model
membranes by spin-label studies [51,52] and on erythrocyte mem-
branes [53]. The conclusion that GSLs may occur on biomembranes
in clusters was complicated by potential pitfalls in those studies: it
was not veriﬁed whether maybe the GSLs in the liposomes were in
solid gel domains, which do not occur in mammalian membranes,
or whether clustering was due to redistribution caused by the
labeling with multivalent ligands. It was then proposed that the
self-aggregation of GSLs was functionally relevant in the lumenal
leaﬂet of the TGN membrane, where it is part of the mechanism
for enriching GSLs on the apical surface of kidney and intestinal
epithelia [54]. These surfaces are virtually covered by GSLs. Clus-
tering of GSLs has been directly observed on the plasma membrane
of non-epithelial cells. While in most studies it could not be ex-
cluded that clustering was induced by the use of multivalent li-
gands [18], in a reliable study using immuno-electron
microscopy after freeze-substitution Parton demonstrated that
the ganglioside GM1 (negatively charged sialic acid containing
GSL) was enriched in caveolae [55]. Also the presence of GM1 in
detergent-resistant membranes has been taken as evidence that
it resided in microdomains or ‘‘rafts”, but it was clearly demon-
strated by microscopy [56] that detergent extraction resulted in
large detergent-resistant domains that had not been observed be-
fore the detergent was added.
Nowadays, the general perception of rafts is that under resting
conditions in plasma membranes rafts are transient nanoscale cho-
lesterol-dependent assemblies of speciﬁc lipids and proteins,
where interactions with speciﬁc proteins, scaffolds and membrane
lipids inﬂuence the formation, stability and size of the cluster
[57,58]. These nanoclusters (20 nm diameter, <10 proteins and
<1000 lipids) may occur on both sides of the plasma membrane.
In homogeneous model membranes a large scale phase segregation
can be driven by the induction of curvature with a radius of 20 nm
[59]. Plasma membranes may generally be close to a point where
the nanoclusters coalesce into large domains [60]. This behavior
has been observed after incubating T-cells in the cold [61], andafter release of the plasma membrane from the underlying cyto-
skeleton combined with temperature reduction [62]. Nanocluster
coalescence has been observed in physiological processes: signal-
ing by EGF [63], cross-linking of lipids by toxin and subsequent
membrane invagination [60,64], and obviously membrane budding
from caveolae [55]. GPI-proteins, anchored to the outside of the
membrane by a glycosylphosphatidylinositol lipid tail, in steady
state reside in cholesterol-dependent nanoclusters [65], but not
in caveolae. Indeed, different GPI-proteins on the same plasma
membrane have been observed to occur in spatially different rafts
[66,67] having different lipid compositions [68]. Interestingly, also
different GSLs, like the gangliosides GM1 and GM3 [69–72], were
found to reside in unique rafts. In line with this, the various GSLs
displayed unique distributions over the different cellular mem-
branes [73]. The coexistence of different types of lipid rafts in the
same membrane provides another layer of complexity to the phys-
iological functions of these structures.
2.6. Glycosphingolipids and their trans- and cis-interactions
GSLs are used as cell surface receptors by a number of toxins,
viruses, bacteria and parasites, and it is now realized that in many
cases the lateral partitioning behavior of the gangliosides is crucial
for correct delivery of the infectious agent to its target organelle. In
addition, GSLs have been proposed to fulﬁll a role in cell–cell rec-
ognition, whereby a GSL on one cell would bind in trans to a lectin,
or even to a different GSL on a neighboring cell [74] similar to car-
bohydrate-based glycoprotein–glycoprotein interactions found be-
fore. This concept was later extended by the idea that the
glycosylated molecules might aggregate into a ‘‘glycosynapse” that
would strongly enhance the binding by multivalency (reviewed in
[75]). The glycosynapse could be formed by two opposed lipid rafts
where binding selectively depends on GSL–GSL interactions in
trans. Alternatively, a GSL raft on one cell could be recognized by
lectins on the neighboring cell. Interestingly, in speciﬁc cases the
recognition of GSL by antibodies was found to depend on the pres-
ence of other GSLs [76]. More recently, disease cases have been re-
ported where autoimmune antibodies turned out to be directed
against a combination of different GSLs, while not binding to the
GSLs when presented individually [77]. In other cases, GSLs on
the cell surface were shielded against anti-GSL antibodies by other
GSLs [78]. These observations are of utmost importance for disease
pathology, but, in addition, similar phenomena may be involved in
the regulation of glycoconjugate-mediated (and GSL-mediated in
particular) cell–cell and cell–matrix interactions. The aggregation
and segregation of GSLs on the cell surface described above may
be part of such regulatory processes. In the ER membrane GlcCer
was found needed for organizing the Shiga toxin receptor, the
GSL Gb3, in lipid rafts as deﬁned by detergent-resistance [79].
The lateral interactions of GSLs are not limited to their aggrega-
tion into lipid nanoclusters or rafts. Early observations demon-
strated an inhibitory action of speciﬁc gangliosides on cell
growth, and suggested that gangliosides modulate receptors [80].
Later work suggested that the ganglioside GM3 directly interacted
with N-linked sugars on the extracellular domain of the activated
EGF receptor to inhibit its receptor tyrosine kinase activity [81–
83], and that GM3 induced the receptor’s presence in detergent-re-
sistant membranes, suggesting a change in the organization of the
receptor and its coreceptor ErbB2 on the cell surface [84]. Similar
interactions have been described for other receptors, like the insu-
lin receptor [85] and for integrins, in which case GM3 and GM2
mediated the interaction of the integrins with other proteins [75].
Possibly, gangliosides form an indispensable part of the machinery
allowing other regulatory factors to modulate the process. Even
more likely, changes in the concentration and lipid tail composition
of the ganglioside are directly relevant for the signaling processes in
1804 G. van Meer, S. Hoetzl / FEBS Letters 584 (2010) 1800–1805which the ganglioside-binding proteins are involved. It is therefore
important to learn about the glycosyltransferases in the Golgi, the
transport of the ganglioside to and from the cell surface, its lateral
organization in relation to the relevant receptors, and its degrada-
tion. Of utmost importance in the regulation appears to be the desi-
alylation and inactivation by sialidases on the plasma membrane
[86]. First of all, the presence of sialidases on the surface appears
to be regulated, second, they display properties of lipid raft pro-
teins, third, they may work in cis on gangliosides in the same mem-
brane, but may also work in trans on gangliosides present in the
opposed membrane upon the establishment of cell–cell contact.
Sialidases preferentially cleave the sialic acid on GM3 and the ter-
minal sialic acids on the complex GSLs. GM1 is a good substrate
only in the presence of a lysosomal activator protein (see [86]).
3. Perspectives
Sphingolipids are evolutionary old lipids, and they are applied
by eukaryotic cells for a number of basic structural functions, for
general physiological signaling pathways like survival and apopto-
sis, and for a number of more speciﬁc signaling functions like mod-
ulating interactions with receptors and integrins. It is a challenge to
unravel the biophysical and chemical backgrounds of these func-
tions and to ﬁnd out the molecular mechanisms by which cells
and organisms utilize these molecules for their vital functions.
Whereas so far most efforts have been directed at mapping the ba-
sic physical principles that govern sphingolipid behavior, the loca-
tion of the various sphingolipids, and the identiﬁcation of the
enzymes and transporters involved, the major challenge for the
next years is to ﬁnd out how cells and organisms sense and vary
the concentration of the various sphingolipids to suit their local
needs, and how at the same time they are able to integrate their
sphingolipid metabolism and transport at the cellular or whole
body level. The sphinx has kept to itself some of its most intriguing
secrets.
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